Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Emily Walck"'
Autor:
Agnieszka Czechowicz, Rahul Palchaudhuri, Amelia Scheck, Yu Hu, Jonathan Hoggatt, Borja Saez, Wendy W. Pang, Michael K. Mansour, Tiffany A. Tate, Yan Yi Chan, Emily Walck, Gerlinde Wernig, Judith A. Shizuru, Florian Winau, David T. Scadden, Derrick J. Rossi
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-12 (2019)
Hematopoietic stem cell (HSC) transplantation is a desirable treatment for many non-malignant and malignant diseases, but its use requires preconditioning of recipients with irradiation or chemotherapy that often induces high toxicity. Here the autho
Externí odkaz:
https://doaj.org/article/9ffac621975f4bccb6eaeafd10b5ba55
Autor:
Rajni Agarwal, Alice Bertaina, Rofida Nofal, Gopin Saini, Nivedita Kunte, Sushmita Sen, Yan Yi Chan, Hana Willner, Matthias Felber, Mark R. Krampf, Maite Van Hentenryck, Emily Walck, Amelia Scheck, Supawat Thongthip, Aaron C. Logan, Kirstin Dougall, Alisha Bouge, Jaap Jan Boelens, Janel Renee Long-Boyle, Robertson Parkman, Irving L Weissman, Judith A. Shizuru, Wendy W. Pang, Maria Grazia Roncarolo, Matthew H. Porteus, Agnieszka Czechowicz
Publikováno v:
Transplantation and Cellular Therapy. 29:S163-S164
Autor:
Margaret M. Kozak, Frederick M. Dirbas, Emily Walck, Rie von Eyben, Clare E. Jacobson, Kathleen C. Horst, Paulina M. Gutkin
Publikováno v:
Clinical Breast Cancer. 20:431-438
Background Optimal surgical management of limited axillary nodal disease following neoadjuvant chemotherapy (NAC) for breast cancer is evolving. Concerns exist with respect to leaving residual disease in the axilla when omitting axillary lymph node d
Autor:
Bilal Nadeem, Galym Imanbayev, Daniel Kraft, Michael J. McCullough, Maia A. Mosse, Lin Song, Antonio Carrasco, Michael D. Crocker, Agnieszka Czechowicz, Emily Walck, Marc Long
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:219-229
Bone marrow (BM) is a rich source of hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs), and other important stem/progenitor cells. It is the traditional source of cells used in hematopoietic cell transplantation, which is a proven curati
Autor:
Tiffany A. Tate, David T. Scadden, Emily Walck, Judith A. Shizuru, Rahul Palchaudhuri, Yu Hu, Jonathan Hoggatt, Wendy W. Pang, Amelia Scheck, Yan-Yi Chan, Michael K. Mansour, Borja Saez, Agnieszka Czechowicz, Derrick J. Rossi, Florian Winau, Gerlinde Wernig
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-12 (2019)
Nature Communications
Nature Communications
Hematopoietic stem cell transplantation (HSCT) is a curative therapy for blood and immune diseases with potential for many settings beyond current standard-of-care. Broad HSCT application is currently precluded largely due to morbidity and mortality
Autor:
Meena Vemuri, Paulina M. Gutkin, Margaret M. Kozak, Carol Marquez, Jamie J. Karl, Emily Walck, Rie von Eyben, Kathleen C. Horst, Clare E. Jacobson
Publikováno v:
Clinical breast cancer. 21(4)
We evaluated the impact of postmastectomy radiotherapy (PMRT) or supraclavicular radiation therapy (SCV RT) in women with cT1-3N1 breast cancer (BC) who became node negative (ypN0) after neoadjuvant chemotherapy (NAC).We retrospectively reviewed 485
Autor:
Kozak, Margaret M., von Eyben, Rie, Gutkin, Paulina M., Vemuri, Meena, Jacobson, Clare E., Karl Emily Walck, Jamie J., Marquez, Carol, Horst, Kathleen C., Karl, Jamie J, Walck, Emily
Publikováno v:
Clinical Breast Cancer; Aug2021, Vol. 21 Issue 4, p373-382, 10p
Autor:
Kathleen C. Horst, Clare E. Jacobson, Erqi L. Pollom, Margaret M. Kozak, Emily Walck, Rie von Eyben, Melinda L. Telli
Publikováno v:
Clinical breast cancer. 18(5)
To identify patterns of distant failure (DF) in premenopausal women receiving neoadjuvant chemotherapy (NAC) for breast cancer.Premenopausal patients treated with NAC between 2005 and 2015 at a single institution were retrospectively reviewed. Timing